Drug
Marlotamig clinical trials
Also written REGN7075.
- studies test it
- 3
- open now
- 3
- in phase 3
- 0
- first study started
- 2026
Keep track of what changes. Save the marlotamig studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Regeneron Pharmaceuticals (1) · NSABP Foundation Inc (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses marlotamig is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)RecruitingPhase 2Regeneron PharmaceuticalsNCT07154290Written as Marlotamig
- A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)RecruitingPhase 2NSABP Foundation IncNCT07058012Written as cemiplimab + REGN7075
- Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal CancerRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07281768Written as REGN7075
Given in every arm · 2 — marlotamig is usual care beside what is tested
- A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingPhase 2Regeneron PharmaceuticalsNCT06465329Written as REGN7075
- A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersActive, not recruitingPhase 1/2Regeneron PharmaceuticalsNCT04626635Written as REGN7075
Codes
What other systems call marlotamig · ClinicalTrials.gg INT014146
- UNII (FDA) 02Z59O1UOMMARLOTAMIGOne source FDA
- NCI Thesaurus C178284MarlotamigOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 02Z59O1UOM | MARLOTAMIG | One source FDA |
| NCI Thesaurus | C178284 | Marlotamig | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.